Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care).

Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care). Circulation. 2017 May 16; 135(20):1911-1921.

View in: PubMed

subject areas

Acute Coronary Syndrome
Aged
Biomarkers
Diabetes Mellitus, Type 2
Double-Blind Method
Female
Humans
Hypoglycemic Agents
Male
Middle Aged
Piperidines
Standard of Care
Treatment Outcome
Troponin I
Uracil

authors with profiles

George Bakris